Cowealth Medical China Co.,Ltd. (SHA:603122)
China · Delayed Price · Currency is CNY 13.98
+0.34 (2.49%)
At close: Sep 21, 2026
Cowealth Medical China Market Cap
Cowealth Medical China has a market cap or net worth of 5.56 billion as of September 21, 2026. Its market cap has increased by 108.97% in one year.
Market Cap
5.56B
Enterprise Value
5.46B
Revenue
648.86M
Ranking
n/a
PE Ratio
n/a
Stock Price
13.98
ChartMarket Cap Chart
Since February 16, 2022, Cowealth Medical China's market cap has increased from 2.40B to 5.56B, an increase of 131.84%. That is a compound annual growth rate of 20.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 21, 2026 | 5.56B | -42.70% |
| Dec 31, 2025 | 9.71B | 248.07% |
| Dec 31, 2024 | 2.79B | -12.92% |
| Dec 29, 2023 | 3.20B | -28.13% |
| Dec 30, 2022 | 4.46B | 85.74% |
| Feb 16, 2022 | 2.40B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Dian Diagnostics Group | 11.62B |
| Amoy Diagnostics | 6.95B |
| Beijing Strong Biotechnologies,Inc. | 6.67B |
| Shanghai Runda Medical Technology | 5.80B |
| Maccura Biotechnology Co.Ltd | 5.49B |
| Shanghai Labway Clinical Laboratory | 4.38B |
| Guangdong Hybribio Biotech | 3.70B |
| Medicalsystem Biotechnology | 3.65B |